Metabolic syndrome in obese adolescents in a double-blind, placebo-controlled study to evaluate treatment with sibutramine

被引：0
|
作者：
Daniels, S
Caprio, S
Hewkin, A
Blakesley, V
机构：
[1] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] Abbott, Abbott Pk, IL USA
来源：
CIRCULATION | 2005年 / 112卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3837
引用
下载
收藏
页码：U908 / U909
页数：2
相关论文
共 50 条
  • [1] Dyslipidemia in obese adolescents: A double-blind, placebo-controlled study to evaluate treatment with sibutramine
    Berkowitz, R
    Hazan, L
    Jasinsky, O
    Blakesley, V
    OBESITY RESEARCH, 2005, 13 : A26 - A27
  • [2] Demographics: Prevalence of metabolic syndrome in obese adolescents from a double-blind, placebo-controlled study to evaluate treatment with sibutramine
    Daniels, S
    Pierson, M
    Hewkin, A
    Blakesley, V
    OBESITY RESEARCH, 2005, 13 : A133 - A133
  • [3] Demographics: Waist circumference of obese adolescents in a double-blind, placebo-controlled study to evaluate sibutramine treatment
    Fujioka, K
    Smith, D
    Walch, J
    Blakesley, V
    OBESITY RESEARCH, 2005, 13 : A192 - A192
  • [4] Results of a double-blind, placebo-controlled study to evaluate treatment of obese adolescents with sibutramine - Efficacy and safety
    Berkowitz, R
    Fujioka, K
    Hewkin, A
    Walch, J
    Peng, J
    Blakesley, V
    Renz, C
    OBESITY RESEARCH, 2004, 12 : A28 - A29
  • [5] Results of a double-blind, placebo-controlled study to evaluate treatment of obese adolescents with sibutramine - Lipid effects
    Fennoy, I
    Berkowitz, R
    Gordon, S
    Hewkin, A
    Blakesley, V
    DIABETES, 2005, 54 : A438 - A438
  • [6] Results of a double-blind, placebo-controlled study to evaluate treatment of obese adolescents with sibutramine - Mood and QoL
    Berkowitz, R
    Perry, A
    Hewkin, A
    Jasinsky, O
    Renz, C
    OBESITY RESEARCH, 2004, 12 : A49 - A49
  • [7] Echocardiogram results from a double-blind, placebo-controlled study to evaluate the safety and efficacy of sibutramine in the treatment of obese adolescents
    Fujioka, K
    Gordon, S
    Hewkin, A
    Blakesley, V
    DIABETES, 2005, 54 : A438 - A438
  • [8] Cardiovascular effects of sibutramine in the treatment of obese adolescents: Results of a randomized, double-blind, placebo-controlled study
    Daniels, Stephen R.
    Long, Barbara
    Crow, Scott
    Styne, Dennis
    Sothern, Melinda
    Vargas-Rodriguez, Ileana
    Harris, Lisa
    Walch, Julia
    Jasinsky, Olga
    Cwik, Kristine
    Hewkin, Ann
    Blakesley, Vicky
    PEDIATRICS, 2007, 120 (01) : E147 - E157
  • [9] Treatment of obese adolescents with sibutramine: A randomized, double-blind, controlled study
    Godoy-Matos, A
    Carraro, L
    Vieira, A
    Oliveira, J
    Guedes, EP
    Mattos, L
    Rangel, C
    Moreira, RO
    Coutinho, W
    Appolinario, JC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03): : 1460 - 1465
  • [10] Results of a double-blind, placebo-controlled study to evaluate treatment of obese adolescents with sibutramine-mean change in vital signs by BMI responder category
    Long, B
    Crow, S
    Hewkin, A
    Blakesley, V
    DIABETES, 2005, 54 : A437 - A437
12345